BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38452266)

  • 1. Clinically Relevant Laboratory Monitoring of Gender-Affirming Hormone Therapy in Transgender People-Experiences from a Teaching Hospital in the Netherlands.
    Pouw N; van der Linden J; Teuben S; Kos S
    J Appl Lab Med; 2024 May; 9(3):440-455. PubMed ID: 38452266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-affirming hormone treatment: friend or foe? Long-term follow-up of 755 transgender people.
    Santi D; Spaggiari G; Marinelli L; Cacciani M; Scipio S; Bichiri A; Profeta A; Granata ARM; Simoni M; Lanfranco F; Manieri C; Ghigo E; Motta G
    J Endocrinol Invest; 2024 May; 47(5):1091-1100. PubMed ID: 37889433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
    Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
    J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory Changes During Gender-Affirming Hormone Therapy in Transgender Adolescents.
    Millington K; Lee JY; Olson-Kennedy J; Garofalo R; Rosenthal SM; Chan YM
    Pediatrics; 2024 May; 153(5):. PubMed ID: 38567424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicians in the Veterans Health Administration initiate gender-affirming hormone therapy in concordance with clinical guideline recommendations.
    Jasuja GK; Wolfe HL; Reisman JI; Vimalananda VG; Rao SR; Blosnich JR; Livingston NA; Shipherd JC
    Front Endocrinol (Lausanne); 2024; 15():1086158. PubMed ID: 38800485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy.
    Hashemi L; Zhang Q; Getahun D; Jasuja GK; McCracken C; Pisegna J; Roblin D; Silverberg MJ; Tangpricha V; Vupputuri S; Goodman M
    J Sex Med; 2021 Sep; 18(9):1662-1675. PubMed ID: 34366264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender-affirming hormone therapy and cardiovascular health in transgender adults.
    Ong C; Monita M; Liu M
    Climacteric; 2024 Jun; 27(3):227-235. PubMed ID: 38597210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-Term Effects of Gender-Affirming Hormone Therapy on Dysphoria and Quality of Life in Transgender Individuals: A Prospective Controlled Study.
    Foster Skewis L; Bretherton I; Leemaqz SY; Zajac JD; Cheung AS
    Front Endocrinol (Lausanne); 2021; 12():717766. PubMed ID: 34394009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and rapid efficacy of guideline-based gender-affirming hormone therapy: an analysis of 388 individuals diagnosed with gender dysphoria.
    Meyer G; Mayer M; Mondorf A; Flügel AK; Herrmann E; Bojunga J
    Eur J Endocrinol; 2020 Feb; 182(2):149-156. PubMed ID: 31751300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of and factors associated with the use of gender-affirming hormonal therapy outside the reference regimen among transgender people in a community-led clinic in Metro Manila, Philippines: a retrospective cross-sectional study.
    Eustaquio PC; Dela Cruz JDM; Araña Y; Rosos B; Rosadiño JDT; Pagtakhan RG; Regencia ZJG; Baja ES
    BMJ Open; 2023 Sep; 13(9):e072252. PubMed ID: 37669846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which U.S. States' Medicaid Programs Provide Coverage for Gender-Affirming Hormone Therapy and Gender-Affirming Genital Surgery for Transgender Patients?: A State-by-State Review, and a Study Detailing the Patient Experience to Confirm Coverage of Services.
    Zaliznyak M; Jung EE; Bresee C; Garcia MM
    J Sex Med; 2021 Feb; 18(2):410-422. PubMed ID: 33422448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender affirming hormonal treatment in Danish transgender persons: A nationwide register-based study.
    Glintborg D; Rubin KH; Kristensen SB; Lidegaard Ø; T'Sjoen G; Hilden M; Andersen MS
    Andrology; 2022 Jul; 10(5):885-893. PubMed ID: 35366390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-affirming hormone therapy and the risk of sex hormone-dependent tumours in transgender individuals-A systematic review.
    McFarlane T; Zajac JD; Cheung AS
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):700-711. PubMed ID: 30107028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Real-World Characteristics of Gender-Affirming Hormonal Use Among Transgender People in Thailand.
    Ittiphisit S; Amponnavarat S; Manaboriboon N; Korpaisarn S
    Sex Med; 2022 Jun; 10(3):100513. PubMed ID: 35428019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous Thromboembolism and Estrogen-Containing Gender-Affirming Hormone Therapy.
    Dix C; Moloney M; Tran HA; McFadyen JD
    Thromb Haemost; 2024 May; 124(5):387-398. PubMed ID: 37816389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sperm quality in transgender women before or after gender affirming hormone therapy-A prospective cohort study.
    Rodriguez-Wallberg KA; Häljestig J; Arver S; Johansson ALV; Lundberg FE
    Andrology; 2021 Nov; 9(6):1773-1780. PubMed ID: 33683832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effect of gender-affirming hormone treatment on depression and anxiety symptoms in transgender people: A prospective cohort study.
    Aldridge Z; Patel S; Guo B; Nixon E; Pierre Bouman W; Witcomb GL; Arcelus J
    Andrology; 2021 Nov; 9(6):1808-1816. PubMed ID: 32777129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
    Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
    Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Gender-Affirming Hormone Therapy on Serum Creatinine in Transgender Individuals.
    Maheshwari A; Dines V; Saul D; Nippoldt T; Kattah A; Davidge-Pitts C
    Endocr Pract; 2022 Jan; 28(1):52-57. PubMed ID: 34474185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and Safety of Different Estradiol Regimens in Transgender Women (TREAT Study): Protocol for a Randomized Controlled Trial.
    Cortez S; Moog D; Lewis C; Williams K; Herrick C; Fields M; Gray T; Guo Z; Nicol G; Baranski T
    JMIR Res Protoc; 2023 Dec; 12():e53092. PubMed ID: 38133914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.